DTCM-Glutarimide Hinders Growth of Childhood Leukemia Cells but Fails to Improve the Efficacy of Commonly Used Chemotherapeutic Agents
[ Vol. 13 , Issue. 1 ]
Author(s):
Julia A. Pezuk, Gabriela M. Roberto, Kazuo Umezawa and Maria Sol Brassesco Pages 41 - 46 ( 6 )
Abstract:
Background: Despite the progressive improvement in current treatment, one fourth of children with acute lymphoblastic leukemia (ALL) still relapse and endure dismal prognosis. In the present study, we introduce more evidence of the antiproliferative effects of 3-[(dodecylthiocarbonyl)-methyl]- glutarimide (DTCM-g), a novel synthetic derivative of 9-methylstreptimidone, on four childhood ALL derived cell lines.
Keywords:
DTCM-g, leukemia, cell lines, drugs, chemotherapy, growth.
Affiliation:
Department of Biology, Faculty of Philosophy, Sciences and Letters at Ribeirão Preto, University of São Paulo, Av, Bandeirantes, 3900, Bairro Monte Alegre, CEP 14040-901, Ribeirão Preto - SP, Brazil.
Graphical Abstract:
Read Full-Text article
No comments:
Post a Comment